Radiotherapy modulates expression of EGFR, ERCC1 and p53 in cervical cancer

Cervical cancer is a public health problem and the molecular mechanisms underlying radioresistance are still poorly understood. Here, we evaluated the modulation of key molecules involved in cell proliferation, cell cycle and DNA repair in cervical cancer cell lines (CASKI and C33A) and in malignant...

ver descrição completa

Detalhes bibliográficos
Autor principal: de Almeida,V.H. (author)
Outros Autores: de Melo,A.C. (author), Meira,D.D. (author), Pires,A.C. (author), Nogueira-Rodrigues,A. (author), Pimenta-Inada,H.K. (author), Alves,F.G. (author), Moralez,G. (author), Thiago,L.S. (author), Ferreira,C.G. (author), Sternberg,C. (author)
Formato: article
Idioma:eng
Publicado em: 2018
Assuntos:
Cervical cancer
Radiotherapy
Epidermal growth factor receptor (EGFR)
p53
Excision repair cross-complementation group 1 (ERCC1)
Texto completo:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2018000100608
País:Brasil
Oai:oai:scielo:S0100-879X2018000100608

Texto Completo

http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2018000100608

Registos relacionados